Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in Primary Hyperparathyroidism
NCT00936650Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 1999
- Primary completion
- Mar 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cinacalcet in primary hyperparathyroidism (PHPT), sponsored by Amgen. Started Nov 1999; status: completed.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT00936650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936650.